1 |
180 Life Sciences Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
2 |
2cureX AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
3 |
3-D Matrix Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
4 |
4Basebio AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
5 |
4D Molecular Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
6 |
4d Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
7 |
4Sc AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
8 |
89bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
9 |
9 Meters Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
10 |
AB Science SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
11 |
AbCellera Biologics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
12 |
Abion Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
13 |
Abionyx Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
14 |
Abivax SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
15 |
ABL Bio Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
16 |
Abliva AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
17 |
AC Immune SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
18 |
Acasti Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
19 |
Acceleron Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
20 |
Aclaris Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
21 |
Actinium Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
22 |
Actinogen Medical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
23 |
Active Biotech AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
24 |
Adaptimmune Therapeutics PLC - ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
25 |
Adaptive Biotechnologies Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
26 |
ADC Therapeutics SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
27 |
AddLife AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
28 |
Adial Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
29 |
Adicet Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
30 |
ADiTx Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
31 |
Adocia SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
32 |
Advagene Biopharma Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
33 |
Adverum Biotechnologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
34 |
Aegis Sciences Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
35 |
Aeglea Bio Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
36 |
Aerpio Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
37 |
Aevi Genomic Medicine, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
38 |
Affimed NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
39 |
Affinor Growers Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
40 |
Agalawatte Plantations PLC (Sri Lanka) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
41 |
Agile Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
42 |
AgResearch Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
43 |
Aikido Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
44 |
Aileron Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
45 |
Aimmune Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
46 |
Akari Therapeutics PLC (ADR) (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
47 |
Akero Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
48 |
Akeso Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
49 |
Albany Molecular Research, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2017 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
50 |
Aldevron (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
51 |
Aldeyra Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
52 |
Alector Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
53 |
Aligos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
54 |
Allarity Therapeutics A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
55 |
Allena Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
56 |
Alligator Bioscience AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
57 |
Allogene Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
58 |
Allovir Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
59 |
Alphamab Oncology (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
60 |
ALS Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
61 |
ALX Oncology Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
62 |
AlzeCure Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
63 |
Alzinova AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
64 |
Ambrx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2014 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
65 |
American Cryostem Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
66 |
Ampio Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
67 |
Amplia Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
68 |
AnaptysBio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
69 |
Anavex Life Sciences Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
70 |
Anchiano Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
71 |
Anchiano Therapeutics Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
72 |
AnGes Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
73 |
Annovis Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
74 |
Antengene Corp Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
75 |
Anteotech Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
76 |
Antibe Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
77 |
Antisense Therapeutics Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
78 |
APact Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
79 |
Apellis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
80 |
Aposense Ltd. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
81 |
Applied BioCode Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
82 |
Applied Biosciences Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
83 |
Applied Genetic Technologies Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
84 |
Applied Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
85 |
Applus Services SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
86 |
Aprea Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
87 |
AptaBio Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
88 |
Aptamer Sciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
89 |
Aptinyx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
90 |
Aqua Bio Technology ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
91 |
Aquabounty Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
92 |
Aran Research and Development 1982 Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
93 |
Aravive Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
94 |
ArborGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2010 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
95 |
Arbutus Biopharma Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
96 |
ArcAroma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
97 |
Arch Biopartners Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
98 |
ArcherDX, Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
99 |
Arcturus Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
100 |
Arcus Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
101 |
Arcutis Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
102 |
Ardelyx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
103 |
Ardentec Corporation (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
104 |
argenx SE (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
105 |
Aridis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
106 |
Arix Bioscience PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
107 |
AroCell AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
108 |
Arrowhead Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
109 |
Artefact SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
110 |
Artelo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
111 |
Arterra Bioscience SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
112 |
Asarina Pharma AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
113 |
Ascelia Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
114 |
Ascendis Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
115 |
Ascentage Pharma Group International (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
116 |
Aslan Pharmaceuticals Ltd (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
117 |
Aslan Pharmaceuticals Ltd (ADR) (Singapore) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
118 |
Atara Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
119 |
Atea Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
120 |
Athira Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
121 |
Atreca Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
122 |
aTyr Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
123 |
Audentes Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
124 |
Aurinia Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
125 |
Auris Medical Holding Ltd (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
126 |
Australian Primary Hemp Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
127 |
Autolus Therapeutics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
128 |
Avacta Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
129 |
Avantium NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
130 |
Avicanna Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
131 |
AVRA Medical Robotics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
132 |
Avrobio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
133 |
Axcella Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
134 |
Axonics Modulation Technologies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
135 |
Axsome Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
136 |
Ayala Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
137 |
AzurRx BioPharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
138 |
BACHEM HOLDING AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
139 |
BARD1 Life Sciences Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
140 |
Basilea Pharmaceutica AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
141 |
Battelle Memorial Institute (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2018 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
142 |
Baudax Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
143 |
BBI Life Sciences Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
144 |
Beam Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
145 |
Beigene Ltd (ADR) (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
146 |
Bellerophon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
147 |
Bellicum Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
148 |
Benitec Biopharma Inc (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
149 |
Bergenbio ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
150 |
Beyondspring Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
151 |
BGI Genomics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
152 |
Bicycle Therapeutics PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
153 |
Bio Synectics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
154 |
Bio-Path Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
155 |
Bio-Thera Solutions Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
156 |
Bio-Works Technologies AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
157 |
Bioanalytical Systems, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
158 |
BioArctic AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
159 |
biOasis Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
160 |
BioClinica Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2012 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
161 |
Biocore Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
162 |
Biodesix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
163 |
Bioextrax AB publ (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
164 |
Biogend Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
165 |
Biohaven Pharmaceutical Holding Co Ltd (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
166 |
BioInvent International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
167 |
BioLASCO Taiwan Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
168 |
Biomm SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
169 |
Biomx Inc (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
170 |
Biondvax Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
171 |
Biondvax Pharmaceuticals Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
172 |
Bioneer Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
173 |
BioNexus Gene Lab Coporation (Malaysia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
174 |
Bionomics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
175 |
Biophytis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
176 |
BIOQUAL, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
177 |
BioRestorative Therapies Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
178 |
Biotron Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
179 |
Biovaxys Technology Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
180 |
Bioventix PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
181 |
Biovica International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
182 |
BioVie Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
183 |
BioXcel Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
184 |
Bioxyne Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
185 |
Black Diamond Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
186 |
Blirt SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
187 |
bluebird bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
188 |
Blueprint Medicines Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
189 |
Bonree Data Technology Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
190 |
Boston Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
191 |
Botanix Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
192 |
BPH Energy Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
193 |
Brain Biotechnology RCH & Info Netwk AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
194 |
Braster SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
195 |
Briacell Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
196 |
BrightPath Biotherapeutics Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
197 |
British Standards Institution (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
198 |
BTC Health Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
199 |
C4 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
200 |
C4X Discovery Holdings PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
201 |
Cabaletta Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
202 |
Caladrius Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
203 |
Callitas Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
204 |
CanBas Co Ltd (Parent) (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
205 |
Cancer Rop Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
206 |
Cannabis Global Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
207 |
Cannabis Suisse Corp (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
208 |
Cannabix Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
209 |
Cannasouth Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
210 |
Cannomed Medical Cannabis Industries Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
211 |
Cannpal Animal Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
212 |
Cansino Biologics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
213 |
Cansino Biologics Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
214 |
Cantargia AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
215 |
Carbios SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
216 |
Cardax Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
217 |
Carna Biosciences, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
218 |
Cassiopea SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
219 |
Castle Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
220 |
Catabasis Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
221 |
Ceapro Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
222 |
Celcuity Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
223 |
Cell MedX Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
224 |
Cellect Biotechnology Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
225 |
Cellectis SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
226 |
Cellectis SA (ADR) (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
227 |
Cellid Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
228 |
Cellivery Therapeutics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
229 |
Cellmid Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
230 |
Cello Health PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
231 |
CellSeed Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
232 |
Cellular Biomedicine Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
233 |
Centogene NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
234 |
Centre Testing International Grp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
235 |
Cerecor Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
236 |
Cerevel Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
237 |
Chabiotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
238 |
Charles River Laboratories Intl. Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/26/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
239 |
Check Cap Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
240 |
Checkmate Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
241 |
Checkpoint Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
242 |
ChemPartner PharmaTech Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
243 |
Chimerix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
244 |
China Building Mtrl Tst Certn Gp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
245 |
China Health Group Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
246 |
China Leon Inspection Holding Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
247 |
Chinook Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
248 |
Chiome Bioscience Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
249 |
Cidara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
250 |
Clal Biotechnology Industries Ltd. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
251 |
Clearside Biomedical Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
252 |
Clene Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
253 |
Cleveland BioLabs, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
254 |
Clinomics Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
255 |
Clinomics Inc (Parent) (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
256 |
Clinuvel Pharmaceuticals Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
257 |
CNS Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
258 |
Codexis, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
259 |
Codiak BioSciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
260 |
Cognetivity Neurosciences Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
261 |
CogState Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
262 |
CohBar Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
263 |
Coherus Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
264 |
Collplant Biotechnologies Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
265 |
Collplant Biotechnologies Ltd - ADR (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
266 |
Combigene AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
267 |
COMPASS Pathways PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
268 |
Compass Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
269 |
Concert Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
270 |
CorMedix Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
271 |
Cortexyme Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
272 |
Corvus Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
273 |
Cotinga Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
274 |
Creo Medical Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
275 |
Crescita Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
276 |
Crinetics Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
277 |
Crispr Therapeutics AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
278 |
CropLogic Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
279 |
Cross Marketing Group Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
280 |
CTC Centro de Tecnologia Canavieira SA (Brazil) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
281 |
Cullinan Oncology LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
282 |
Curando Nordic AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
283 |
Curasight A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
284 |
CureVac BV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
285 |
CVR Medical Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
286 |
Cyclerion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
287 |
CymaBay Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
288 |
Cynata Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
289 |
Cytogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
290 |
CytomX Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
291 |
CytoTools AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
292 |
D.Western Therapeutics Institute Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
293 |
Deepmatter Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
294 |
Deepverge PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
295 |
DEKRA SE (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
296 |
DermTech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
297 |
Deutsche Biotech Innovativ AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
298 |
Deveron Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
299 |
Dextech Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
300 |
DiaMedica Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
301 |
Diamyd Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
302 |
Dicerna Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
303 |
Diffusion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
304 |
Digipath Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
305 |
Dimerix Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
306 |
DNA Biomedical Solutions Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
307 |
DNA Chip Research Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
308 |
DNA Link Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
309 |
Double Bond Phrmctcl Intnl AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
310 |
Dova Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
311 |
DreamCIS Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
312 |
DT&C Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
313 |
DV Biomed Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
314 |
Dyadic International, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
315 |
Dynata (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
316 |
Dyne Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
317 |
e-Therapeutics plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
318 |
Edesa Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
319 |
Egetis Therapeutics AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
320 |
EGF Theramed Health Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
321 |
Eidos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
322 |
Eiger Biopharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
323 |
Element Materials Technology Group US Holding Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
324 |
Eloxx Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
325 |
Emerald Bioscience Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
326 |
Endonovo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
327 |
ENDRA Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
328 |
Energenesis Biomedical Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
329 |
Enimmune Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
330 |
Enlivex Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
331 |
Enochian Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
332 |
Entasis Therapeutics Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
333 |
Entera Bio Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
334 |
Entheon Biomedical Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
335 |
Eone Diagnomics Genome Center Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
336 |
Epizyme Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
337 |
EPS Holdings Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
338 |
Erection Electromechanics Testing JSC (Vietnam) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
339 |
eResearch Technology, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2012 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
340 |
Ergomed PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
341 |
Esense-Lab Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
342 |
ESSA Pharma Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
343 |
ETREND Hightech Corp. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
344 |
Eurocine Vaccines AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
345 |
Eurofins Scientific SE (Luxembourg) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
346 |
Eurofins-Cerep SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
347 |
European Institute of Science AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
348 |
Evelo Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
349 |
Evgen Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
350 |
Evogene Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
351 |
Evolus Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
352 |
Evolutionary Genomics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
353 |
Evolva Holding SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
354 |
EXACT Sciences Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
355 |
Exact Therapeutics AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
356 |
Exelixis, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
357 |
Exicure Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
358 |
Exopharm Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
359 |
Explorer Holdings, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
Statement |
News |
SEC |
Bankruptcy |
Suits |
Liens |
360 |
Eyegate Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
361 |
F-Star Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
362 |
Factor Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
363 |
Faron Pharmaceuticals Oy (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
364 |
Femtobiomed Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
365 |
FibroGen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
366 |
Field Trip Health Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
367 |
Fiji Kava Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
368 |
Five Prime Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
369 |
Fluicell AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
370 |
Fluoguide AS (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
371 |
Follicum AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
372 |
Foresee Pharmaceuticals Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
373 |
Formycon AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
374 |
Forrester Research, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
375 |
Forte Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
376 |
Fortress Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
377 |
Forty Seven, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
378 |
Fraunhofer-Gesellschaft zur Forderung der angewandten Forsch (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
379 |
Freeline Therapeutics Holdings PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
380 |
Frequency Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
381 |
Frontage Holdings Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
382 |
FunPep Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
383 |
Fusion Antibodies PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
384 |
Fusion Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
385 |
Futura Medical plc. (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
386 |
G&E Herbal Biotechnology Co., Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
387 |
G1 Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
388 |
Galapagos NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
389 |
Galecto Inc (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
390 |
Galera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
391 |
Galmed Pharmaceuticals Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
392 |
Gamida Cell Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
393 |
Gene Techno Science Co Ltd (Parent) (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
394 |
Genematrix Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
395 |
Generation Bio Co (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
396 |
GeNeuro SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
397 |
Genexine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
398 |
Genfit SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
399 |
GenKyoTex SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
400 |
Genmab A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
401 |
Genome&Company (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
402 |
Genomic Vision SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
403 |
Genomics BioSci &Tech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
404 |
Genovis AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
405 |
genOway SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
406 |
Genprex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
407 |
Genscript Biotech Corp (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
408 |
Gensight Biologics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
409 |
Genus plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
410 |
Genxone SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
411 |
Geovax Labs Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
412 |
Gevo Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
413 |
GFC Green Fields Capital Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
414 |
GL Pharm Tech Corp (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
415 |
Global Blood Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
416 |
Global Information Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
417 |
GlycoMimetics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
418 |
GlycoNex Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
419 |
GMO Research Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
420 |
GNI Group Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
421 |
Go D M Investments Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
422 |
Goldenwell Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
423 |
Gongwin Biopharm Holdings Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
424 |
Gossamer Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
425 |
GRAIL Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
426 |
Graybug Vision Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
427 |
Greenland Resources Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
428 |
Guangdong Leadyo IC Testing Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
429 |
Guangzhou Kingmed Diagnostics Grp Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
430 |
Guard Therapeutics Intrntnl AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
431 |
Gunsynd PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
1/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
432 |
GW Pharmaceuticals PLC- ADR (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
433 |
Hadasit Bio Holding Ltd. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
434 |
Hamlet Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
435 |
Hansa Biopharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
436 |
Harpoon Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
437 |
HAVN Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
438 |
HCT Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
439 |
Healios KK (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
440 |
Heidelberg Pharma AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
441 |
Helix Biopharma Corp. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
442 |
Hemogenyx Pharmaceuticals PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
443 |
Hemostemix Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
444 |
Hepion Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
445 |
Herantis Pharma Oyj (Finland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
446 |
HitGen Inc (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
447 |
HLB Life Science Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
448 |
Holista Colltech Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
449 |
Hoth Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
450 |
HRL Holdings Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
451 |
Hua Medicine (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
452 |
Human Metabolome Technologies Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
453 |
Iaso Biomed Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
454 |
IBEX Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
455 |
Ibio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
456 |
Icagen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
457 |
iCo Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
458 |
ICON PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
459 |
Idogen AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
460 |
IDT Australia Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
461 |
Imara Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
462 |
Immatics NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
463 |
Immunic Inc (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
464 |
Immunicum AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
465 |
Immunome Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
466 |
Immunotech Biopharm Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
467 |
Immunovant Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
468 |
Immunovia AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
469 |
ImmuPharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
470 |
Immutep Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
471 |
Imugene Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
472 |
Imv Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
473 |
IN8BIO, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
474 |
Incanthera PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
475 |
Incyte Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
476 |
Infas Holding AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
477 |
Inflarx NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
478 |
Inhibikase Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
479 |
Inhibitor Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
480 |
Inhibrx Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
481 |
Inibio Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
482 |
Initiator Pharma A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
483 |
INmune Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
484 |
Innate Pharma SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
485 |
Inno-Gene SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
486 |
Innovation Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
487 |
Innovotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
488 |
Inozyme Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
489 |
Institut za Crnu Metalurgiju ad Niksic (Montenegro) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
490 |
Intage Holdings Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
491 |
Intec Pharma Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
492 |
Intech Biopharm Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
493 |
IntegraGen SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
494 |
Integrated Service Technology Inc. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
495 |
Intellia Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
496 |
Intertek Group plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
497 |
Intervacc AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
498 |
Invap SE (Argentina) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
499 |
Inventionmed SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
500 |
Inventiva SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
501 |
Invex Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
502 |
Invion Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
503 |
Iovance Biotherapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
504 |
Ipsos SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
505 |
Iqvia Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
506 |
ISR Immune System Rgultn Hldg AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
507 |
iTeos Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
508 |
Iterum Therapeutics PLC (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
509 |
IVERIC bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
510 |
IXICO PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
511 |
Jacobio Pharmaceuticals Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
512 |
Japan Tissue Engineering Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
513 |
Jeevan Scientific Technology Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
514 |
JHBP CY Holdings Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
515 |
Joinn Laboratories China Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
516 |
Jounce Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
517 |
Jugoinspekt ad Beograd (Serbia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
518 |
JW Cayman Therapeutics Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
519 |
Kadimastem Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
520 |
Kainos Medicine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
521 |
Kainos Medicine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
522 |
Kalvista Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
523 |
Kalytera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
524 |
Kamada Ltd. (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
525 |
Kane Biotech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
526 |
Kang Stem Biotech Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
527 |
Karessa Pharma Holding AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
528 |
Karuna Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
529 |
Karyopharm Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
530 |
Kazia Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
531 |
KBR, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
532 |
KemPharm Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
533 |
Keros Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
534 |
Kezar Life Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
535 |
Kiadis Pharma NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
536 |
Kindred Biosciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
537 |
Kiniksa Pharmaceuticals Ltd (Bermuda) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
538 |
Kinnate Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
539 |
Kintara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
540 |
Kintor Pharmaceutical Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
541 |
Kiromic Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
542 |
Klaria Pharma Holding AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
543 |
Kodiak Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
544 |
Kolon TissueGene Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
545 |
Kringle Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
546 |
Kronos Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
547 |
Krystal Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
548 |
Kura Oncology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
549 |
Kuros Biosciences AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
550 |
Kymera Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
551 |
Lantern Pharma Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
552 |
Larimar Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
553 |
LBT Innovations Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
554 |
Leap Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
555 |
Legend Biotech Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
556 |
Legochem Biosciences Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
557 |
Lexagene Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
558 |
Lidds AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
559 |
Lifecare AS (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
560 |
Likhami Consulting Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
561 |
Liminal BioSciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
562 |
Linical Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
563 |
Lipocine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
564 |
Liquidia Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
565 |
Living Cell Technologies Ltd. (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
566 |
Luminex Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
567 |
Lumosa Therapeutics Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
568 |
Luna Innovations Incorporated (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
569 |
Lysogene SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
570 |
Mabion SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
571 |
Macrogen Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
572 |
Macromill Embrain Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
573 |
Macromill Embrain Co Ltd - Parent (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
574 |
Macromill Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
575 |
Magenta Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
576 |
Majestic Research Services & Sltns Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
577 |
Manhattan Scientifics Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
578 |
Marizyme Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
579 |
Materials Analysis Technology Inc. (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
580 |
Matinas BioPharma Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
581 |
Mavens Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
582 |
MaxCyte Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
583 |
Mayo Foundtn fr Medicl Eductn nd Rsrch (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2012 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
584 |
MDxHealth SA (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
585 |
Meat-Tech 3D Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
586 |
Med Biogene Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
587 |
Medicago Inc. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2013 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
588 |
Medical Data Vision Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
589 |
Medicenna Therapeutics Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
590 |
Medicure Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
591 |
Medigen Biotechnology Corporation (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
592 |
MediGene AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
593 |
MEDINET CO., LTD. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
594 |
Medipost Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
595 |
Medivir AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
596 |
Medizen Humancare Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
597 |
Medlab Clinical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
598 |
Medpace Holdings Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
599 |
Medpacto Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
600 |
MEDRx Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
601 |
Mereo BioPharma Group PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
602 |
Mersana Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
603 |
Mertiva AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
604 |
Merus NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
605 |
Mesoblast limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
606 |
Mesoblast limited (ADR) (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
607 |
Metacrine Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
608 |
Microbix Biosystems Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
609 |
Midatech Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
610 |
Milestone Pharmaceuticals Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
611 |
Millendo Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
612 |
Millennium Food Tech LP (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
613 |
Mind Cure Health Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
614 |
Mind Medicine (MindMed) Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
615 |
Mirati Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
616 |
Mirum Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
617 |
Modalis Therapeutics Corp (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
618 |
Moderna Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
619 |
Molecular Medicine SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
620 |
Molecular Partners AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
621 |
Mologen AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
622 |
Monopar Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
623 |
Moogene Medi Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
624 |
MORISHITA JINTAN CO., LTD. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
625 |
MorphoSys AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
626 |
Motif Bio PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
627 |
Ms&Consulting Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
11/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
628 |
Mustang Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
629 |
Mydecine Innovations Group Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
630 |
Myokardia Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
631 |
Myovant Sciences Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
632 |
Nabriva Therapeutics PLC - ADR (Ireland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
633 |
NanHua Bio-medicine Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
634 |
Nanobiotix SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
635 |
NanoCarrier Co., Ltd. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
636 |
Nanoflex Power Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
637 |
Nanogroup SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
638 |
NanoRepro AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
639 |
NanoViricides Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
640 |
Nantkwest Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
641 |
Nascent Biotech Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
642 |
National Milk Records Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
643 |
National Research Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
644 |
National Technical Systems, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2013 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
645 |
NatureCell Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
646 |
NeoGenomics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
647 |
Neoleukin Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
648 |
NeonMind Biosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
649 |
Neovacs SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
650 |
Neptune Wellness Solutions Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
651 |
Nerium Biotechnology Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
652 |
Neuren Pharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
653 |
Neurobo Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
654 |
Neuropathix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
655 |
Neuroscientific Biopharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
656 |
Newron Pharmaceuticals SpA (Italy) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
657 |
Next Science Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
658 |
Nextage Therapeutics Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
659 |
NextCell Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
660 |
NextCure Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
661 |
NKMax Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
662 |
NLS Pharmaceutics AG (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
663 |
Nordic Nanovector ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
664 |
Northern Data AG (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
665 |
Northwest Biotherapeutics, Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
666 |
Nova Mentis Life Science Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
667 |
Novoheart Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
668 |
Novus Group International AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
669 |
NOXXON Pharma NV (Germany) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
670 |
NuCana PLC (ADR) (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
671 |
Nuformix PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
672 |
Numinus Wellness Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
673 |
Nurix Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
674 |
OBI Pharma Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
675 |
Oceanaa Biotek Industries Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
676 |
Ocular Therapeutix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
677 |
Odyssey Group International Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
678 |
OKYO Pharma Corporation (Isle of Man) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
679 |
OKYO Pharma Ltd (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
680 |
Olema Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
681 |
OliX Pharmaceuticals Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
682 |
OncBioMune Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
683 |
Oncodesign SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
684 |
Oncolys Biopharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
685 |
Oncosil Medical Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
686 |
OncoTherapy Science, Inc. (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
687 |
Open Orphan PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
688 |
Opiant Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
689 |
Opthea Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
690 |
ORIC Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
691 |
Origin Agritech Ltd. (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
692 |
Orphazyme A/S (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
693 |
Ortho Regenerative Technologies Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
694 |
Oryzon Genomics SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
695 |
Ose Immunotherapeutics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
696 |
Otonomy Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
697 |
Ovid Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
698 |
Oxford Biodynamics PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
699 |
Oxford BioMedica plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
700 |
Oxurion NV (Belgium) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
701 |
Oyster Point Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
702 |
P&K Skin Research Center Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
703 |
Pacgen Life Science Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
704 |
Pacific Edge Ltd (New Zealand) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
705 |
Panagene Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
706 |
Pandion Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
707 |
Pangaea Oncology SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
708 |
PanGen Biotech Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
709 |
Paradigm Biopharmaceuticals Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
710 |
PAREXEL International Corporation (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2017 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
711 |
Pascal Biosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
712 |
Passage Bio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
713 |
Patrys Limited (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
714 |
PaxMedica Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
715 |
PCI Biotech Holding ASA (Norway) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
716 |
PDS Biotechnology Corp (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
717 |
Peijia Medical Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
718 |
Peptidream Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
719 |
Peptonic Medical AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
720 |
Personalis Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
721 |
Petros Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
722 |
Pfenex Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
723 |
Pharma Mar SA (Spain) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
724 |
PharmAbcine Inc (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
725 |
Pharmaceutical Product Development, LLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2011 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
726 |
Pharmacore Biotech Co Ltd (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
727 |
Pharmadax Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
728 |
PharmaEngine Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
729 |
Pharmaron Beijing Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
730 |
Pharmaron Beijing Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
731 |
Pharmaxis Ltd. (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
732 |
Pharmaxis Ltd. (ADR) (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
733 |
Pharmigene Inc (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
734 |
PhaseBio Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
735 |
Phathom Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
736 |
PhoenixBio Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
737 |
Physiomics Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
738 |
Phytohealth Corp (Taiwan, Republic of China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
739 |
Pieris Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
740 |
Plant Advanced Technologies PAT SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
741 |
PLx Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
742 |
Polaris Group (Cayman Islands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
743 |
Pond Technologies Holdings Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
744 |
Pony Testing International Group Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
745 |
Poseida Therapeutics, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
746 |
Powerlong Commercial Management Hlgs Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
747 |
Poxel SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
748 |
PPD Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
749 |
PRA Health Sciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
750 |
Praxis Precision Medicines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
751 |
Precision BioSciences Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
752 |
Predictive Technology Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
753 |
Predilife SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
754 |
Prelude Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
755 |
Prevail Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
756 |
Principia Biopharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
757 |
Promis Neurosciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
758 |
Promore Pharma AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
759 |
ProQR Therapeutics NV (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
760 |
Protagonist Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
761 |
Protara Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
762 |
Proteo Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
763 |
Proteomics International LaboratoriesLtd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
764 |
Psomagen Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
765 |
Pulmatrix Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
766 |
Pureprofile Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
767 |
Puretech Health PLC (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
768 |
PYC Therapeutics Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
769 |
Q linea AB (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
770 |
Qualigen Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
771 |
Quanta Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
772 |
Quantum Genomics SA (France) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
773 |
Quest PharmaTech Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
774 |
Quintiles Transnational (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2005 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
775 |
Qurient Co Ltd (South Korea) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
776 |
R J Biotech Ltd (India) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
777 |
Ra Pharmaceuticals, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
778 |
Race Oncology Ltd (Australia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
779 |
Radiotekhnicheskiy inst akadmk A.L.M OAO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
780 |
Radius Health Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
781 |
Ramm Pharma Corp (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
7/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
782 |
Rapt Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
783 |
RaQualia Pharma Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
784 |
Rayont Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
785 |
Read-Gene SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
786 |
Reata Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
787 |
Recro Pharma Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
788 |
RedHill Biopharma Ltd (Israel) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
789 |
Redx Pharma PLC (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
3/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
790 |
Regenicin Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
791 |
Regenxbio Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
792 |
Regulus Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
793 |
RELIEF THERAPEUTICS Holding SA (Switzerland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
794 |
Relmada Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
795 |
RemeGen Co Ltd (China) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
796 |
ReNeuron Group Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
797 |
Repare Therapeutics Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
798 |
RepliCel Life Sciences Inc (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
799 |
Replimune Group Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
800 |
Respiratorius AB (publ) (Sweden) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
801 |
Resverlogix Corp. (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
802 |
Revance Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
803 |
Reviva Pharmaceuticals Holdings, Inc. (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
8/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
804 |
Revive Therapeutics Ltd (Canada) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
805 |
Revolution Medicines Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
806 |
Rhythm Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
807 |
Ribomic Inc (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
808 |
Rocket Pharmaceuticals Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
809 |
RoodMicrotec N.V. (Netherlands) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
6/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
810 |
Rosnano AO (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
12/31/2019 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
811 |
Rosnano AO (Parent) (Russia) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
812 |
Rubius Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
813 |
Ryvu Therapeutics SA (Poland) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
814 |
SAGE Therapeutics Inc (United States) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
815 |
SanBio Co Ltd (Japan) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
10/31/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
816 |
Saniona AB (Denmark) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
DBRS |
9/30/2020 |
News |
SEC |
Bankruptcy |
Suits |
Liens |
817 |
Sareum Holdings Plc (United Kingdom) |
FRISK® |
Z'' |
PAYCE® |
DBT |
Moody's |
Fitch |
|